The insider sales are too small relative to market cap to be informative. The CMO's $198K sale is consistent with routine diversification after earnings. The CTO's sale was a same-day exercise-and-sell of options, not a directional bet. The CEO's grant suggests retention, not concern. Monitor the SL-325 Phase 1 data readout in Q2 2026 as the primary catalyst.
Price Chart
Executive Summary
Two senior executives at Shattuck Labs (CMO and CTO) sold a combined $212K in open-market shares on May 12, 2026, one week after the company reported Q1 2026 earnings that showed continued pre-revenue status with a net loss of -$0.13/share. The CTO also exercised options at $3.57/share and sold the resulting shares, while the CEO received a grant of 25,610 shares at $1.08. The total sales represent ~0.04% of market cap, which is trivial and likely driven by routine portfolio diversification rather than a negative signal.
Key Financial Metrics
Key Facts
- CMO Pandite sold 30,000 shares at $6.61 for $198K on May 12
- CTO Shukla sold 2,032 shares at $7.01 for $14K on May 12 after exercising options at $3.57
- CEO Schreiber received a grant of 25,610 shares at $1.08 on May 12 (non-cash)
- Total open-market sales of $212K represent ~0.04% of $518M market cap
- Q1 2026 net loss of -$0.13/share was slightly better than consensus of -$0.14; company remains pre-revenue
- Cash runway extended to 2029 with $90.4M on hand; Phase 1 SL-325 data expected Q2 2026
Financial Impact
Open-market insider sales of $212K, or 0.04% of market cap — immaterial relative to company size
Risk Factors
- Pre-revenue biotech with no approved products; stock price driven by clinical data, not fundamentals
- Insider sales could accelerate if SL-325 data disappoints
- Cash runway into 2029 provides buffer but dilution risk remains if trials expand
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-STTK-1778803538572 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 10w ago | 8-K | $7.18 $7.45 | ▲ +3.76% | ▲ +4.16% | $5.54 (−22.84%) |
Aug 11, 2026 10w ago | Press Release | $7.18 $7.45 | ▲ +3.76% | ▲ +4.16% | $5.54 (−22.84%) |
Jul 7, 2026 15w ago | Insider Cluster | $6.88 $6.29 | ▼ −8.58% | ▼ −9.44% | $5.54 (−19.48%) |
Jul 2, 2026 16w ago | Insider Cluster | $7.05 $7.03 | ▼ −0.28% | ▼ −1.21% | $5.54 (−21.42%) |
Jun 11, 2026 19w ago | 8-K | $4.18 $4.74 | ▼ −13.40% | ▼ −12.96% | $5.54 (−32.54%) |
Jun 11, 2026 19w ago | Institutional Cluster | $4.18 $4.74 | ▼ −13.40% | ▼ −12.96% | $5.54 (−32.54%) |
Jun 11, 2026 19w ago | 424B5 | $4.18 $4.74 | ▼ −13.40% | ▼ −12.96% | $5.54 (−32.54%) |
Jun 10, 2026 19w ago | Press Release | $4.13 $4.33 | ▼ −4.84% | ▼ −1.41% | $5.54 (−34.14%) |
Jun 9, 2026 19w ago | 424B5 | $4.13 $4.33 | ▼ −4.84% | ▼ −1.41% | $5.54 (−34.14%) |
Jun 9, 2026 19w ago | 8-K | $4.13 $4.33 | ▲ +4.84% | ▲ +1.41% | $5.54 (+34.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers